Effects of three serotonin reuptake inhibitors on sign-tracking in male Sprague-Dawley rats

被引:1
作者
Holden, John M. [1 ]
机构
[1] Winona State Univ, Dept Psychol, 230-B Phelps Hall,175 West Mark St, Winona, MN 55987 USA
关键词
Sign; -tracking; Addiction; Serotonin; Fluoxetine; Escitalopram; Citalopram; PREFRONTAL CORTEX; ANIMAL-MODELS; FLUOXETINE; CITALOPRAM; ANXIETY; ESCITALOPRAM; BEHAVIORS; ALCOHOL; COCAINE; IMIPRAMINE;
D O I
10.1016/j.physbeh.2023.114233
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Sign-tracking is a behavior with relevance to cue-triggered relapse addiction, a Pavlovian conditioned approach behavior directed at the conditioned stimulus. The study examined one strategy for reducing the magnetic pull of drug-associated conditioned stimuli, using selective serotonin reuptake inhibitors (SSRIs) citalopram (0, 10, and 20 mg/kg), escitalopram (0, 10, and 20 mg/kg) and fluoxetine (0, 5, and 10 mg/kg). Male Sprague-Dawley rats were first trained in a standard sign-tracking task and then acutely administered these drugs in a series of three experiments. In each study, it was found that measures of sign-tracking were reduced, although effects on goal -tracking were different between drugs. This study provides evidence that administration of serotonergic anti-depressants is effective in reducing sign-tracking and may have some efficacy in preventing cue-triggered relapse.
引用
收藏
页数:13
相关论文
共 40 条
  • [1] From sign-tracking to attentional bias: Implications for gambling and substance use disorders
    Anselme, Patrick
    Robinson, Mike J. F.
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2020, 99
  • [2] Adjunctive Treatment with Asenapine Augments the Escitalopram-Induced Effects on Monoaminergic Outflow and Glutamatergic Neurotransmission in the Medial Prefrontal Cortex of the Rat
    Bjorkholm, Carl
    Franberg, Olivia
    Malmerfelt, Anna
    Marcus, Monica M.
    Konradsson-Geuken, Asa
    Schilstrom, Bjorn
    Jardemark, Kent
    Svensson, Torgny H.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2015, 18 (03)
  • [3] Psychedelics in the treatment of unipolar and bipolar depression
    Bosch, Oliver G.
    Halm, Simon
    Seifritz, Erich
    [J]. INTERNATIONAL JOURNAL OF BIPOLAR DISORDERS, 2022, 10 (01)
  • [4] Bourke CH, 2013, PSYCHOPHARMACOLOGY, V228, P231, DOI 10.1007/s00213-013-3030-z
  • [5] INFLUENCE OF DOSE AND ROUTE OF ADMINISTRATION ON THE KINETICS OF FLUOXETINE AND ITS METABOLITE NORFLUOXETINE IN THE RAT
    CACCIA, S
    CAPPI, M
    FRACASSO, C
    GARATTINI, S
    [J]. PSYCHOPHARMACOLOGY, 1990, 100 (04) : 509 - 514
  • [6] Role of prefrontal 5-HT in the strain-dependent variation in sign-tracking behavior of C57BL/6 and DBA/2 mice
    Campus, P.
    Accoto, A.
    Maiolati, M.
    Latagliata, C.
    Orsini, C.
    [J]. PSYCHOPHARMACOLOGY, 2016, 233 (07) : 1157 - 1169
  • [7] FLUOXETINE REDUCES INTRAVENOUS COCAINE SELF-ADMINISTRATION IN RATS
    CARROLL, ME
    LAC, ST
    ASENCIO, M
    KRAGH, R
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1990, 35 (01) : 237 - 244
  • [8] Fluoxetine versus placebo for the marijuana use of depressed alcoholics
    Cornelius, JR
    Salloum, IM
    Haskett, RF
    Ehler, JG
    Jarrett, PJ
    Thase, ME
    Perel, JM
    [J]. ADDICTIVE BEHAVIORS, 1999, 24 (01) : 111 - 114
  • [9] Additive effect of rimonabant and citalopram on extracellular serotonin levels monitored with in vivo microdialysis in rat brain
    Emilio Ortega, Jorge
    Gonzalez-Lira, Victor
    Horrillo, Igor
    Herrera-Marschitz, Mario
    Felipe Callado, Luis
    Javier Meana, J.
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 709 (1-3) : 13 - 19
  • [10] Serotonin receptors as potential targets for modulation of nicotine use and dependence
    Fletcher, Paul J.
    Le, Anh Dzung
    Higgins, Guy A.
    [J]. SEROTONIN-DOPAMINE INTERACTION: EXPERIMENTAL EVIDENCE AND THERAPEUTIC RELEVANCE, 2008, 172 : 361 - 383